Daily digest
The news of Tuesday, October 20, UTC.
DeepSeek technology banned by US government
The US government banned the use of Chinese AI startup DeepSeek's technology in federal agencies, citing security risks, while DeepSeek responded by open-sourcing its DeepInfer inference engine. Otter.ai secured $320 million in funding to advance its AI meeting assistant and expand internationally. Additionally, OpenAI acquired Orchestra Bio to enhance its AI capabilities in drug development and life sciences research. These developments highlight ongoing tensions in AI geopolitics alongside significant investments in enterprise AI and biotech applications.
599 articles116 sources1 min read
The top 5
| Rank | Keyword | Mentions | Trend score |
|---|---|---|---|
| 01 | DeepSeek | 15 | 2.00 |
| 02 | China | 10 | 1.55 |
| 03 | US | 8 | 1.42 |
| 04 | Otter.ai | 4 | 1.33 |
| 05 | Orchestra Bio | 4 | 1.33 |
Why they trended
Written by AI from the period’s articles. Mentions and trend scores are computed from the data.
The US bans Chinese AI startup DeepSeek's products from federal agencies over security concerns while DeepSeek releases its DeepInfer inference framework as open source.
Read the articles on DeepSeekOtter.ai
4 mentionsOtter.ai raises $320 million from General Catalyst’s Customer Value Fund to boost enterprise growth, marketing, international expansion, and AI meeting assistant innovation.
Read the articles on Otter.aiOrchestra Bio
4 mentionsOpenAI acquires Orchestra Bio to integrate its AI agents and technology into Rosalind, enhancing AI-driven drug development and life sciences research tools.
Read the articles on Orchestra BioGet every issue: RSS feed or Bluesky (opens in a new tab).